Fig. 4

Comparisons of clinicopathological and molecular features among three TIDE subtypes in the BC patients. A Sankey diagram showing sample flows for TIDE subtype, sample type, pathological stage (pStage), TCGA Subtype, hSubtype, and survival status. B The proportion of sample type among the TIDE subtypes of UC.Combi cohort. C Comparisons of age at diagnosis among TIDE subtypes. D–G The proportion of pathological T stage (pT) (D), hGrade (E), hSubtype (F) and TCGA Subtype (G) among the three TIDE subtypes. H Comparisons of total copy number variations (CNV), amplifications and deletions among three TIDE subtypes. I Oncoplots showing the top 20 mutated genes in SI (left), SII (middle), and SIII (right). J Heatmap showing mutually exclusive or co-occurrence events among top mutated genes in SI (left), SII (middle), and SIII (right). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns, no significance